Human Cancer-Targeted Immunity via Transgenic Hematopoietic Stem Cell Progeny
Demographics (3)
- AGE - Subject age at enrollment (phv00556486.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00556493.v1.p1)
- SEX - Biological sex (phv00556481.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00556485.v1.p1)
Other (14)
- AGE_ONSET - Disease onset age (phv00556487.v1.p1)
- ANALYTE_TYPE - Analyte type (phv00556490.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00556489.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00556480.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00556492.v1.p1)
- IS_TUMOR - Tumor status (phv00556491.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00556494.v1.p1)
- SAMPLE_ID - Sample ID (phv00556488.v1.p1)
- SAMPLE_ID - Sample ID (phv00556483.v1.p1)
- SUBJECT_ID - Subject ID (phv00556484.v1.p1)
- SUBJECT_ID - Subject ID (phv00556479.v1.p1)
- SUBJECT_ID - Subject ID (phv00556482.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00556495.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00556496.v1.p1)